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All patients undergoing HOLEP and TURP 
between August 6, 2015, to September 20, 
2017, were identified and included in this pilot 
retrospective cohort study. The study protocol 
was approved a priori by the LVHN Institutional 
Review Board. The primary outcome was 
total hospital length of stay (LOS). Secondary 
outcomes were total cost, volume of tissue 
resected, and 6- and 12-week post-operative 
changes in maximum urine flow rate (Qmax), 
post-void residual (PVR), International Prostate 
Symptom Score (IPSS), and Bother Score. 
Data were collected independently among 4 
investigators from review of electronic medical 
records (EMR) using standardized forms and 
analyzed with analysis of variance using SAS 
9.4. 
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Methods
 •  In this study, 51 HOLEP and 155 TURP patients were identified. 
•  On average, HOLEP patients had a LOS that was 11.9 hours shorter than TURP patients (95%CI 4.08 to 
19.7; p=0.003) and saved $267.44 in hospital charges (95%CI -$2.60 to $537.49; p=0.0522; Table 1)
•  At 6-weeks follow-up, HOLEP patients experienced a larger improvement in Qmax (6.9 vs 2.1ml/s; 
p=0.013), decrease in PVR (-263 vs -115ml; p=0.0009), IPSS (-7.0 vs 6.2; p=0.7655), and Bother 
Score (-1.3 vs -1.13; p=0.7587) compared to TURP patients (Table 2)
•  At 12-weeks follow-up, HOLEP patients experience a larger improvement in Qmax (7.1 vs 2.9ml/s; 
p=0.0582), decrease in PVR (-264 vs -118ml; p=0.0007), and IPSS (-9.4 vs -9.0; p=9010), while TURP 
patients experienced a greater decrease Bother Score (-2.0 vs -2.3; p=0.6580; Table 2)
•  HOLEP patients had higher prostatic volume resected (41.5g vs 16.5; p=0.0003).
Results
 In this setting, HOLEP patients experienced shorter LOS and lower costs while reporting overall improved post-operative outcomes compared to TURP patients. This must be interpreted with 
caution, as the largest limitation to this study was incomplete data in the EMR. Many patients were 
lost to follow-up, possibly due to significantly improved symptoms, which highlights selection bias in 
the study. Prospective studies at LVHN are needed with strict patient follow-up to determine a more 
accurate relative impact of HOLEP.
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•  50% of men between ages 51-60 will develop 
benign prostatic hyperplasia (BPH)
•  Holmium Laser Enucleation of the Prostate 
(HOLEP) was introduced as a safer and more 
efficacious surgical technique compared to the 
gold-standard transurethral resection of the 
prostate (TURP)
•  HOLEP is generally performed in high-
volume academic institutions due to the steep 
procedural learning curve and high capital costs 
to the institution
•  Lehigh Valley Health Network (LVHN) is a large 
community-based institution that established 
a HOLEP program and care pathway aimed 
at lowering the costs of surgical treatment 
for BPH, but its effectiveness has not been 
measured
•  This pilot study’s objective is to investigate 
the impact on length of stay (LOS) as a source 
of cost savings compared to TURP in this 
community-hospital setting
 Can we shorten the length of stay through 
implementation of care pathway in HOLEP vs 
traditional TURP procedure, thereby lowing 
cost of BPH treatment, without significant 
differences in post-operative outcomes?
Problem Statement




(n = 155) p-value
 
Length of Stay (hrs) 8.20 (±8.84) 20.10 (±27.84) p=0.0030
Cost of Care $1766.57 (± $507.38) $2034.01 (± $933.38) p=0.0522
Table 2. Procedural Outcomes Between HOLEP and TURP Patients at 6- and
 12-Week Follow-Up
 
6-Week Follow-Up 12-Week Follow-Up
HOLEP TURP p-value HOLEP TURP p-value
 
Change in Qmax 
(ml/s) 6.9 2.1 p=0.013 7.1 2.9 p=0.0582
Change in Post-
Void Residual (ml) -263 -115 p=0.0009 -263 -118 p=0.0007
Change in IPSS -7.0 -6.2 p=0.7655 -9.4 -9.0 p=0.9010
Change in Bother 
Score -1.3 -1.13 p-0.7587 -2.0 -2.3 p=0.6580
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